Font Size:
a
A
A
Keyword [Apolipoprotein E deficient mice]
Result: 21 - 34 | Page: 2 of 2
21.
Functional Blockage Of EMMPRIN Ameliorates Atherosclerosis In Apolipoprotein E-deficient Mice
22.
CD137-CD137L Interaction Regulates Atherosclerosis Via Cyclophilin A In Apolipoprotein E-deficient Mice
23.
Preparation Of A Novel Amphiphilic Low Molecular Weight Chondroitin Sulfate And Its Inhibitory Effects On Atherosclerotic Plaques In Apolipoprotein E-deficient Mice
24.
Effects Of Curcumin Nicotinate On Lipid Metabolism And Inflammation In Apolipoprotein E-deficient Mice
25.
The Study Of Varying The Ratios Of DHA/EPA On Atherosclerosis In Apolipoprotein E Deficient Mice
26.
Effects Of Reconstructed PEP-1-hMsrA Protein On Atherosclerosis
27.
Regulator Of G P Rotein Signalling 5 Protects Against Atherosclerosis In Apolipoprotein E-deficient Mice
28.
The Effects Of Shexiang Baoxin Pill On The Development Of Atherosclerosis In Apolipoprotein E-deficient Mice Fed HFD
29.
CFTR Protects Against Vascular Inflammation And Atherogenesis In Apolipoprotein E-deficient Mice
30.
Effects Of Xiaoxian Xiong Decoction On Lipid Metabolism And Expression Of Related Transporters Protein In Apolipoprotein E-Deficient Mice
31.
Loss Of Caspase-Activated Dnase Protects Against Atherosclerosis In Apolipoprotein E-deficient Mice
32.
Interactions of dietary phytosterols with lipid-lowering drugs in apolipoprotein E deficient mice
33.
In vitro studies on the mechanisms responsible for the atherogenic nature of very low density lipoproteins in human subjects with type III or IV hyperlipoproteinemia and in apolipoprotein E deficient mice
34.
The Fucoidan From Seaweed Ascophyllum Nodosum Alleviates The Formation Of Atherosclerotic Plaques In Apolipoprotein E-deficient Mice By Lipid Lowering
<<First
<Prev
Next>
Last>>
Jump to